Total CAC Score Test

Most heart attack risk calculators look at numbers in your blood and try to predict what is happening inside your arteries. A coronary artery calcium scan does something different: it actually looks. Using a quick CT of your chest, it counts the hardened plaque that has already formed in the arteries feeding your heart muscle and turns it into a single number, your Total CAC (coronary artery calcium) Score.

That number is one of the strongest predictors in preventive cardiology. A score of zero is associated with very low short-term risk of heart attack, stroke, and cardiovascular death. A high score, especially above 400, signals that significant disease has already taken hold and that you should be treating it like an existing condition, not a future possibility.

What the Score Is Actually Counting

Atherosclerosis (the buildup of fatty, fibrous plaque inside arteries) is a process that often takes decades. As plaque matures, parts of it calcify. The CT picks up these dense calcium deposits as bright spots and uses a formula called the Agatston score, which combines how much calcium is there with how dense it is. The total is reported in Agatston Units (AU), summed across all your major coronary arteries.

Calcified plaque is a fingerprint of atherosclerosis. You do not get coronary calcium without having had atherosclerosis. That is why the score is such a specific marker of disease that has actually formed in your arteries, rather than a guess based on risk factors.

Heart Attack and Cardiovascular Death

The link between CAC and future cardiovascular events is steep and graded. Risk rises stepwise across the standard categories, and the strongest jumps happen as you cross 100 and then 400 AU.

In adults aged 32 to 46, having any coronary calcium was tied to a meaningful rise in coronary heart disease, cardiovascular disease, and death over follow-up, with scores of 100 or more linked to early mortality. In a Walter Reed cohort of more than 23,000 adults without known cardiovascular disease, CAC scoring substantially improved long-term prediction of major cardiovascular events and mortality compared with risk factors alone.

At the extreme end, asymptomatic adults with CAC at or above 1,000 carry risks of cardiovascular events and death that look more like patients who have already survived a heart attack than typical primary-prevention patients. A score this high is not a warning, it is a diagnosis of advanced atherosclerosis.

Beyond the Heart

Coronary calcium is partly a marker of biological aging in your blood vessels, so its associations stretch beyond cardiovascular outcomes. In the Multi-Ethnic Study of Atherosclerosis, elevated CAC was tied to higher risk of cancer, chronic kidney disease, chronic obstructive pulmonary disease (COPD, a long-term lung condition), pneumonia, and hip fractures. People with CAC of zero, by contrast, were less likely to develop these age-related diseases and have been described as healthy agers.

In people with chronic kidney disease, CAC is common and progressive and predicts heart failure as well as heart attacks. In cancer patients receiving anthracycline chemotherapy, a CAC above zero identifies those at higher risk of treatment-related heart damage. The score is best understood as a global readout of vascular health that happens to live inside your coronaries.

The Power of Zero

A CAC score of zero is one of the most reassuring results in cardiology. In the DISCHARGE chest pain trial of 1,749 adults, a zero score was associated with a very low rate of major adverse cardiovascular events at follow-up. In intermediate-risk adults, a zero often justifies delaying or avoiding statins and aspirin that might otherwise be recommended.

But a zero is not a free pass. In adults under 40 referred for preventive screening, a zero score was less reliable at ruling out plaque on coronary CT angiography, which can detect non-calcified buildup that calcium scoring will miss. Vulnerable, inflamed plaques and microvascular dysfunction can also exist without calcium. If you are young, symptomatic, or have a strong family history of premature heart disease, a zero CAC should not end the conversation.

Research-Based Reference Ranges

The categories below come from large U.S. cohorts including the Multi-Ethnic Study of Atherosclerosis and the Coronary Artery Calcium Consortium, scanned with ECG-gated CT and reported in Agatston Units. Different ethnic groups carry different baseline calcium burdens, which is why age-, sex-, and race-specific percentiles often add useful context, especially in young adults, women, and people of South Asian or East Asian background.

Compare your results within the same imaging center over time, since scanner type and reading protocol can introduce small differences. Percentile context matters too: in a 35-year-old, any visible calcium typically lands above the 90th percentile for age, while in adults over 75, scores above 100 are common and a fixed cutpoint may overcall risk.

The Statin Paradox: When a Rising Score Is Good News

Here is a finding that confuses many people the first time they see it. Adults on statins tend to have higher CAC scores over time than untreated peers, yet they have lower rates of heart attack and death. High-dose, long-term statin therapy actively accelerates the calcification of existing plaque.

This is not a failure of treatment. Statins shift soft, inflamed, rupture-prone plaque toward dense, hardened, more stable plaque. Calcified plaque is less likely to break open and trigger a clot. So in a person on a statin, a rising CAC score over a few years can reflect plaque stabilization rather than worsening disease. The number to watch in that situation is your non-calcified plaque on CT angiography or your overall event risk, not the calcium total alone.

Tracking Your Trend

Calcium does not disappear. Once a deposit forms, it stays. So unlike a blood test where the goal is often to drive a number down, the goal with CAC is to slow how fast the score climbs and to confirm you are responding to treatment in expected ways. This is why a single reading is useful, but a trajectory is much more useful.

A reasonable cadence: get a baseline now if you are 40 or older, or earlier if you have strong family history, diabetes, high Lp(a) (lipoprotein a, an inherited cholesterol particle), or other risk-enhancing factors. If your baseline is zero and you are otherwise low risk, repeating in 5 years is reasonable. If you have any calcium, especially above 100, repeat scans every 3 to 5 years let you see how fast it is progressing and whether your therapy is working as expected. Annual scans are not standard because radiation exposure and incremental information do not justify them.

When Results Can Be Misleading

• Age and sex bias: a young woman with any calcium may be at high relative risk even if the absolute score is low, while an older man with a score under 100 may be lower risk than the number suggests. Use age- and sex-specific percentiles to interpret extremes.
• Non-calcified plaque: a CAC of zero does not exclude soft, vulnerable plaque, particularly in adults under 40. If you have symptoms or strong family history, CT angiography can fill in the gaps.
• Statin effect: if you have been on a statin for years, a rising CAC may reflect plaque hardening rather than worsening disease. Interpret with your overall risk picture, not the score in isolation.
• Scanner and reader variability: different CT scanners and reading protocols can produce small differences in score. Repeating scans at the same imaging center makes serial comparison cleaner.

What to Do With an Abnormal Result

If your score is above zero, especially above 100, treat it as a signal that atherosclerosis is already present and act accordingly. The data supports a few clear next steps. Get a full lipid workup including ApoB (apolipoprotein B, a count of all your atherogenic particles) and Lp(a). Check fasting glucose and HbA1c (a measure of average blood sugar over months). Add hs-CRP (high-sensitivity C-reactive protein, a marker of vascular inflammation) to gauge inflammatory tone.

Scores above 100 in primary prevention generally warrant statin therapy. Scores above 400 or 1,000 warrant more aggressive lipid lowering, blood pressure control, and a conversation with a preventive cardiologist or lipidologist about whether to add ezetimibe, a PCSK9 (proprotein convertase subtilisin/kexin type 9) inhibitor, or further imaging like CT coronary angiography to characterize plaque type. A randomized trial in adults with familial coronary artery disease showed that combining a CAC score with a primary prevention strategy reduced atherogenic lipids and slowed plaque progression compared with usual care.